# Rising Cases of Cannabis Hyperemesis Syndrome Across the US > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-hyperemesis-syndrome-cases-surge-nationwide/ > **Published:** 2026-03-02T09:54:49-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:13:11-04:00 > **Clinical Summary:** Cannabis hyperemesis syndrome cases surge nationwide, highlighting the need for awareness and early diagnosis among healthcare providers. --- ✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchSafetyTHC Why This Matters [Cannabis hyperemesis syndrome](https://cedclinic.com/remediated-cannabis-mold-contamination-risks/) represents an increasingly common diagnosis that clinicians must recognize and differentiate from other causes of severe nausea and vomiting, particularly given the rising prevalence of high-potency cannabis products in circulation. The dramatic increase in CHS-related emergency department visits documented over the past decade suggests this condition warrants integration into standard differential diagnostic algorithms for hyperemesis presentations. Early identification and counseling regarding cannabis cessation remains the only evidence-based intervention, making provider awareness critical to reducing unnecessary diagnostic testing and hospitalizations. Clinical Summary [Cannabis hyperemesis syndrome](https://cedclinic.com/remediated-cannabis-mold-contamination-risks/) (CHS) diagnoses have increased dramatically over the past decade, with a 2025 study documenting 4.4 emergency department visits per 100,000 population attributable to CHS, reflecting a significant [public health](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) trend. The syndrome presents with cyclic nausea, vomiting, and abdominal pain in chronic cannabis users and is thought to result from cannabinoid receptor overstimulation in the gastrointestinal tract, though the precise mechanism remains incompletely understood. Rising CHS prevalence correlates with increased cannabis potency and frequency of use, particularly among daily users consuming high-THC products. Clinicians should maintain a high index of suspicion for CHS in patients with refractory nausea and vomiting who report regular [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/), as the condition is often initially misdiagnosed and subjected to unnecessary diagnostic workup. The definitive treatment remains cannabis cessation, though symptom management during acute episodes may include antiemetics and supportive care. Patients and providers should recognize that CHS represents a genuine clinical entity associated with modern [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) patterns and that cessation remains the only evidence-based cure. Dr. Caplan’s Take “Cannabinoid Hyperemesis Syndrome represents a real and increasingly common presentation in my practice, particularly among patients using high-potency products daily, and I’ve found that early recognition and complete cessation of cannabis use remains the only reliably effective treatment, though many patients struggle with this intervention once dependence has developed.” Clinical Perspective Cannabis hyperemesis syndrome represents an increasingly recognized clinical entity that warrants heightened awareness as cannabis use and potency have expanded substantially in recent years. While the reported rise in CHS diagnoses is striking, clinicians should consider that increased recognition, improved diagnostic criteria, and expanded [cannabis access](https://cedclinic.com/medical-cannabis-delivery-services-growth-dmv-jamaica/) likely contribute to higher case counts alongside any true increase in incidence. The syndrome’s presentation can mimic other causes of intractable nausea and vomiting, including cyclic vomiting disorder and gastroparesis, so a careful history specifically targeting cannabis use patterns and symptom relief with cessation remains essential for accurate diagnosis. Given the potential for diagnostic delay and unnecessary investigations in patients with unrecognized CHS, incorporating direct questioning about cannabis consumption frequency and potency into the evaluation of unexplained hyperemesis may help providers identify this condition earlier and counsel patients on the risk of continued use. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Cannabis+Hyperemesis+Syndrome+cases+rise+nationwide+as+providers+warn+of+growing+...+%40drcaplan&url=https%3A%2F%2Fwww.myarklamiss.com%2Fnews%2Fnational-news%2Fcannabis-hyperemesis-syndrome-cases-rise-nationwide-as-providers-warn-of-growing-public-concern%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.myarklamiss.com%2Fnews%2Fnational-news%2Fcannabis-hyperemesis-syndrome-cases-rise-nationwide-as-providers-warn-of-growing-public-concern%2F) [🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Cannabis+Hyperemesis+Syndrome+cases+rise+nationwide+as+providers+warn+of+growing+...+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.myarklamiss.com%2Fnews%2Fnational-news%2Fcannabis-hyperemesis-syndrome-cases-rise-nationwide-as-providers-warn-of-growing-public-concern%2F) [📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/) [📝 Read more on Substack](https://substack.com/@doctorapproved) [🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - [Daily Digest: Last 8 Hours: Pain, Policy, and the Psychiatric Tradeoffs of Cannabis – March 01, 2026](https://cedclinic.com/cannabis-medicine-maturation-pain-psychiatric-tradeoffs/) 📰 Source: [https://www.myarklamiss.com/news/national-news/cannabis-hyperemesis-syndrome-cases-rise-nationwide-as-providers-warn-of-growing-public-concern/](https://www.myarklamiss.com/news/national-news/cannabis-hyperemesis-syndrome-cases-rise-nationwide-as-providers-warn-of-growing-public-concern/) Further Reading Evidence Watch[The Brain Science Behind the Munchies – Nautilus Magazine](https://cedclinic.com/cannabis-appetite-stimulation-neuroscience/) Evidence WatchIGC Pharma Adds Visionary Investigators Network as Clinical Site to Phase 2 CALMA Trial Research Digest[Daily Digest 2026-03-07](https://cedclinic.com/adolescent-cannabis-psychiatric-outcomes-2026-digest/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabis hyperemesis syndrome cases surge in Virginia ERs – YouTube](https://cedclinic.com/cannabis-hyperemesis-syndrome-virginia-er-cases-surge/) Watch the rise of cannabis hyperemesis syndrome cases in Virginia emergency rooms and learn about clinical presentations and challenges. [Watch Now](https://cedclinic.com/cannabis-hyperemesis-syndrome-virginia-er-cases-surge/) [Bouts of vomiting, nausea and abdominal pain: The little-known syndrome stalking daily …](https://cedclinic.com/bouts-of-vomiting-nausea-and-abdominal-pain-the-little-known-syndrome-stalking-daily/) Explore the symptoms and clinical features of cannabis hyperemesis syndrome affecting daily cannabis users. [Read More](https://cedclinic.com/bouts-of-vomiting-nausea-and-abdominal-pain-the-little-known-syndrome-stalking-daily/) [Screaming, vomiting, and daily weed: The rise of 'scromiting' among chronic cannabis users](https://cedclinic.com/cannabinoid-hyperemesis-syndrome-clinical-overview/) Learn about 'scromiting,' a severe vomiting condition linked to [chronic cannabis use](https://cedclinic.com/cannabis-tolerance-behavioral-models/), and its relation to cannabis hyperemesis syndrome. [Discover More](https://cedclinic.com/cannabinoid-hyperemesis-syndrome-clinical-overview/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).